Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:CRXTW

Clarus Therapeutics (CRXTW) Stock Price, News & Analysis

Clarus Therapeutics logo

About Clarus Therapeutics Stock (NASDAQ:CRXTW)

Advanced Chart

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.01
$1.19
Volume
N/A
Average Volume
134,799 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CRXTW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clarus Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CRXTW Stock News Headlines

ANTX AN2 Therapeutics, Inc.
Clarus Corp.
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?
Clarus Therapeutics Holdings, Inc. (CRXWQ)
Earnings Preview For Clarus
CRXTQ Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. (CRXTQ)
See More Headlines

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:CRXTW
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$16.91 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:CRXTW) was last updated on 2/5/2025 by MarketBeat.com Staff
From Our Partners